Search results
Showing results for
The first patient has now been registered to the ATOM trial, a single-centre (Churchill Hospital, Oxford University Hospitals Trust) pre-operative window of opportunity study of the effects of atovaquone on hypoxia in non-small cell lung carcinoma (NSCLC).
Methods for the development and validation of computable phenotypes based on biobanks and linked real world data
Deadline - Friday 15 May 2026